NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine 11/12/26
November 12, 2026; start time unavailable: Jim Cramer weighs what a Jensen-less NVIDIA could mean for shareholders, breaks down Kraft Heinz’s turnaround pitch and Anthropic’s IPO setup, and interviews Moderna CEO Stéphane Bancel about the company’s cancer vaccine pipeline. Mad Money Disclaimer Hosted by Simplecast, an…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Mad Money w/ Jim Cramer
See all episodes →One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.